OnKure Therapeutics, Inc. (OKUR) financial statements and ratios from SEC XBRL: revenue $3.44M (TTM), net margin -1729.6%, revenue growth 362.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $3.44M |
| Net Margin | -1729.6% |
| Revenue Growth (YoY) | 362.1% |
| EPS Growth (YoY) | -0.9% |
| FCF Growth (YoY) | 34.0% |
| Price / Book | 0.92 |
| Price / Sales | 48.56 |
| FCF Yield | -30.9% |
| Altman Z-Score | -1.63 (distress) |
| Sector P/E (Healthcare) | 21.7 |
OKUR overview · OKUR earnings · OKUR KPIs · OKUR investor relations · OKUR ownership · OKUR peers · OKUR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.